Sky Labs Unveils CART BP pro Platform for Global Pharmaceutical Trials

Sky Labs, based in Seoul, South Korea, announced on July 2 that it presented its data platform, CART BP pro, at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, Switzerland. The platform is intended to facilitate pharmaceutical clinical trials on a global scale.

The CART BP pro platform aims to streamline data collection and analysis within clinical trials. Its objective is to improve the efficiency and accuracy of patient monitoring and the evaluation of new drug efficacy, a crucial step in drug development.

During the event, the company highlighted the capabilities of its solution to integrate data from multiple sources and provide real-time insights to researchers. This could potentially expedite decision-making and reduce the development time for new treatments.

Sky Labs seeks to position its technology as an essential component for pharmaceutical companies conducting complex and large-scale clinical research, particularly where continuous and remote monitoring of participants is required.